1. Red cell alloantibodies in beta-thalassaemia major patients’ blood referring to the regional blood transfusion center of Tehran, Iran

Parisa Ebrahimisadr* , Zahra Bakhshandeh, Hamidreza Majidiani

BioImpacts. 2021;11(2): 129-133. doi: 10.34172/bi.2021.20

PMCID: PMC8022230 PMID: 33842283 Scopus ID: 85106638656

Article

PDF

Full Text

XML

Cited By:

One of the major complications in thalassemia patients is alloimmunization, The best way to manage alloimmunized patients is to identify the type of alloantibodies with antibody screening and identification tests and blood transfusion of the negative antigen.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons